MVCAX | TMCVX | MVCAX / TMCVX | |
Total Expense Ratio | 0.99 | 0.90 | 110% |
Annual Report Gross Expense Ratio | 1.00 | 1.42 | 70% |
Fund Existence | 24 years | 5 years | - |
Gain YTD | 3.325 | 2.645 | 126% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 2000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1B | 23.7M | 72,152% |
Annual Yield % from dividends | 0.86 | 1.19 | 72% |
Returns for 1 year | -3.52 | 3.47 | -101% |
Returns for 3 years | 6.81 | 11.51 | 59% |
Returns for 5 years | 47.65 | 71.90 | 66% |
Returns for 10 years | 63.09 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PQJL | 27.66 | 0.25 | +0.91% |
PGIM NASDAQ-100 BUFFER 12 ETF - JULY | |||
HELX | 29.58 | 0.21 | +0.73% |
Franklin Genomic Advancements ETF | |||
IDOG | 36.00 | 0.23 | +0.64% |
ALPS International Sector Div Dogs ETF | |||
FAAR | 28.92 | 0.02 | +0.06% |
First Trust Alt Abs Ret Strat ETF | |||
SECT | 60.05 | -0.22 | -0.37% |
Main Sector Rotation ETF |